Life Sciences
The Focalist system aims to combine handheld robotics with real-time imaging to enable clinicians to place needles more precisely.
The company will use the funds for a European feasibility study for its transcatheter device and for the launch of a U.S.-based clinical study.
The spin-off company is expected to rake in almost $2 billion in revenue this year.
The acquisition is expected to boost Teleflex's global footprint in the peripheral intervention market.
The AI-based early warning system the NHS is developing is part of the government's 10 Year Health Plan to use data to identify patient safety concerns.
The sale drew mixed reactions, with some U.S. states supporting it as a privacy measure and others objecting over legal and data concerns.
The alliance merges DarioHealth's cardiometabolic and behavioral AI-powered health offering with GreenKey's system for managing obstructive sleep apnea.
Cirrus uses fMRI imaging to acquire and generate maps of critical brain networks to assist with brain surgery planning.
The announcement comes the same week the pharma giant ended its collaboration with Hims & Hers to sell Wegovy, alleging the company engages in deceptive marketing and illegally sells copycat drugs.
The company offers an AI-enabled workflow automation platform for administrative tasks pertaining to specialty medications.